RadNet, Inc.
RDNT
Rang in aandelen
#3240
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Aandeelprijs
$69.56
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$5.47B
Verandering (1 dag)
1.10%
Verandering (1 jaar)
-11.33%
Land
US
Handel RadNet, Inc. (RDNT)
Categorie
Healthcare
Winst voor RadNet, Inc. (RDNT)
Winst in Jun 2026 TTM: $34.98M
Volgens de meest recente financiële verslagen van RadNet, Inc. bedraagt de huidige winst van het bedrijf $34.98M. In 2023 behaalde het bedrijf een winst van $38.81M, een daling ten opzichte van de winst van 2022, die $42.97M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van RadNet, Inc. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $34.98M | -22.03% |
| 2024 | $44.86M | 15.59% |
| 2023 | $38.81M | -9.68% |
| 2022 | $42.97M | -27.02% |
| 2021 | $58.88M | -6,994.50% |
| 2020 | $-854.00K | -102.88% |
| 2019 | $29.67M | -22.99% |
| 2018 | $38.53M | 46.02% |
| 2017 | $26.39M | 112.17% |
| 2016 | $12.44M | -15.08% |
| 2015 | $14.65M | 301.01% |
| 2014 | $3.65M | -37.95% |
| 2013 | $5.89M | -380.42% |
| 2012 | $-2.10M | -171.44% |
| 2011 | $2.94M | -114.45% |
| 2010 | $-20.34M | 99.64% |
| 2009 | $-10.19M | -46.58% |
| 2008 | $-19.07M | 5.18% |
| 2007 | $-18.13M | 163.00% |
| 2006 | $-6.89M | 119.90% |
| 2005 | $-3.14M | -66.44% |
| 2004 | $-9.34M | 74.17% |
| 2003 | $-5.36M | 3.83% |
| 2002 | $-5.17M | -156.26% |
| 2001 | $9.18M | -36.69% |
| 2000 | $14.50M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 21,653.05% |
US
|
|
| $4.76B | 13,513.88% |
US
|
|
| $-252.70M | -822.44% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 4,639.99% |
US
|
